← Back to Clinical Trials
Recruiting NCT07346755

Suprascapular Nerve Block and Proprioception in Hemiplegic Shoulder Pain: A Randomized Controlled Study

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Hemiplegic Shoulder Pain
Sponsor Fatih Sultan Mehmet Training and Research Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 40
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2025-05-01
Completion 2026-03
Interventions
suprascapular nerve blockphysical therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this prospective randomized controlled clinical trial is to evaluate the effect of suprascapular nerve block on shoulder joint proprioception in stroke patients with hemiplegic shoulder pain. Fourteen patients aged 18-80 years with hemiplegic shoulder pain will be randomized into two groups. One group will receive suprascapular nerve block followed by a standardized physical therapy program, while the control group will receive the same physical therapy program alone. The primary outcome is shoulder joint proprioception. Secondary outcomes include pain intensity, shoulder range of motion, motor recovery, stroke-specific quality of life, and upper extremity functional outcomes. The results of this study are expected to clarify the role of suprascapular nerve block on proprioception and rehabilitation outcomes in patients with hemiplegic shoulder pain.

Eligibility Criteria

Inclusion Criteria: * Age between 18 and 80 years * Presence of shoulder pain on the hemiplegic side with a Numeric Rating Scale (NRS) score \> 3 * At least 1 month since the cerebrovascular event (subacute and chronic stroke patients) * Active shoulder flexion range of motion \> 90 degrees (required for the application of the laser pointer-assisted joint position sense test) * First-ever, unilateral hemiplegia Exclusion Criteria: * Mini-Mental State Examination score \< 24 indicating cognitive impairment * Presence of aphasia * Shoulder spasticity with a Modified Ashworth Scale score \> 2 * Brunnstrom upper extremity motor stage \< 3 * Botulinum toxin type A injection within the last 3 months to muscles affecting shoulder joint movement (trapezius, levator scapulae, pectoralis major, deltoid, serratus anterior, latissimus dorsi, rhomboids, teres major, biceps, coracobrachialis, triceps, supraspinatus, subscapularis, infraspinatus, and teres minor) * Pre-existing shoulder pathology cau

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}